Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EXAI
13676
CALL
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $2.44K | ﹤0.01% |
500
-700
| -58% | -$3.67K |
2022 Q2
9 quarters
|
|
|
CCTSW
13677
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
| $2.43K | ﹤0.01% |
101,123
-66,094
| -40% | -$2.62K |
2024 Q2
1 quarter
|
|
13678
Moolec Science SA Warrant
MLECW
$166K
| $2.42K | ﹤0.01% |
60,517
+174
| +0.3% | +$9 |
2024 Q1
2 quarters
|
|
13679
PUT
Intellicheck
IDN
$45.8M
| $2.39K | ﹤0.01% |
1,100
-3,300
| -75% | -$8.65K |
2024 Q2
1 quarter
|
|
|
CASI
13680
CALL
DELISTED
CASI Pharmaceuticals
CASI
| $2.38K | ﹤0.01% |
+400
| New | +$2.59K |
2024 Q3
0 quarters
|
|
13681
PUT
Bakkt Inc
BKKT
$341M
| $2.37K | ﹤0.01% |
248
-132
| -35% | -$1.95K |
2021 Q1
14 quarters
|
|
|
YOTAW
13682
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
| $2.36K | ﹤0.01% |
+112,581
| New | +$2.88K |
2024 Q3
0 quarters
|
|
13683
CALL
Invivyd
IVVD
$247M
| $2.35K | ﹤0.01% |
2,300
+1,000
| +77% | +$1.08K |
2023 Q4
3 quarters
|
|
|
BLEUW
13684
DELISTED
bleuacacia ltd Warrants
BLEUW
| $2.34K | ﹤0.01% |
86,508
+19,890
| +30% | +$382 |
2024 Q2
1 quarter
|
|
13685
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
| $2.31K | ﹤0.01% |
+50,207
| New | +$2.96K |
2024 Q3
0 quarters
|
|
|
MKDWW
13686
MKDWELL Tech Inc Warrants
MKDWW
| $2.31K | ﹤0.01% |
+126,161
| New | +$4.26K |
2024 Q3
0 quarters
|
|
|
AKTS
13687
CALL
DELISTED
Akoustis Technologies Inc
AKTS
| $2.3K | ﹤0.01% |
25,700
-39,300
| -60% | -$3.77K |
2022 Q4
7 quarters
|
|
|
AEAEW
13688
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
| $2.28K | ﹤0.01% |
203,293
+1,896
| +0.9% | +$47 |
2023 Q2
5 quarters
|
|
|
CON
13689
PUT
Concentra Group Holdings
CON
$4.62B
| $2.24K | ﹤0.01% |
+100
| New | +$2.31K |
2024 Q3
0 quarters
|
|
13690
CALL
Cytek Biosciences
CTKB
$792M
| $2.22K | ﹤0.01% |
400
+200
| +100% | +$1.13K |
2024 Q2
1 quarter
|
|
13691
PUT
Viant Technology
DSP
$257M
| $2.21K | ﹤0.01% |
+200
| New | +$2.13K |
2024 Q3
0 quarters
|
|
|
QVCGA
13692
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $2.2K | ﹤0.01% |
72
-60
| -45% | -$1.9K |
2019 Q2
21 quarters
|
|
13693
PUT
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.07B
| $2.19K | ﹤0.01% |
100
-300
| -75% | -$6.33K |
2022 Q4
7 quarters
|
|
13694
CALL
Martin Midstream Partners
MMLP
$82.2M
| $2.19K | ﹤0.01% |
600
-9,600
| -94% | -$34.6K |
2023 Q3
4 quarters
|
|
13695
CALL
OPAL Fuels
OPAL
$53.9M
| $2.19K | ﹤0.01% |
600
+500
| +500% | +$1.88K |
2024 Q1
2 quarters
|
|
13696
CALL
Tredegar Corp
TG
$244M
| $2.19K | ﹤0.01% |
300
-4,700
| -94% | -$27.5K |
2023 Q1
6 quarters
|
|
13697
PUT
LiveOne
LVO
$36.3M
| $2.18K | ﹤0.01% |
230
| – | – |
2024 Q2
1 quarter
|
|
13698
CALL
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$11.5M
| $2.17K | ﹤0.01% |
100
-3,000
| -97% | -$67.1K |
2022 Q3
8 quarters
|
|
13699
PUT
VanEck Social Sentiment ETF
BUZZ
$104M
| $2.15K | ﹤0.01% |
100
-1,200
| -92% | -$25.1K |
2023 Q3
4 quarters
|
|
|
13700
PUT
Invivyd
IVVD
$247M
| $2.14K | ﹤0.01% |
2,100
+1,500
| +250% | +$1.63K |
2023 Q4
3 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.